Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure

Hepatology

Volumn 23, Issue 5, 1996, Pages 1067-1072

  Harrison, Phillip ^a   Wendon, Julia ^a   Williams, Roger ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GUANYLATE CYCLASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; MALE; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; TISSUE OXYGENATION; VASODILATATION;

EID: 0029869775     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008621135     Document Type: Article

References (25)

1. Rueff B, Benhamou JP. Acute hepatic necrosis and fulminant hepatic failure. Gut 1973;14:805-815.
2. Bihari D, Gimson AE, Lindridge J, Williams R. Lactic acidosis in fulminant hepatic failure: some aspects of pathogenesis and prognosis. J Hepatol 1985;1:405-416.
3. Bihari D, Gimson AE, Waterson M, Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985;13:1034-1039.
4. Bihari D, Smithies M, Gimson A, Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987;317:397-403.
5. Bihari DJ, Gimson AE, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis 1986;6:119-128.
6. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GM, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991;303:1026-1029.
7. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324:1852-1857.
8. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. HEPATOLOGY 1994;19:1407-1413.
9. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994;266:H1746-H1754.
10. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983;68:1247-1253.
11. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
12. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3',5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977;74:3203-3207.
13. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
14. Schneider F, Lutun P, Boudjema K, Wolf P, Tempé J-D. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. HEPATOLOGY 1994;19:38-44.
15. Stamler J, Mendelsohn M, Amarante P, Smick D, Andon N, Davies P, Cooke J, et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789-795.
16. Wood KS, Ignarro LJ. Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase. J Biol Chem 1987;262:5020-5027.
17. Jespersen B, Jensen L, Sorensen SS, Pedersen EB. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide. Eur J Clin Invest 1990;20:632-641.
18. Sagnella GA, Singer DR, Markandu ND, MacGregor GA, Shirley DG, Tremblay J, Hamet P. Atrial natriuretic peptide-cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man. Can J Physiol Pharmacol 1990;68:535-538.
19. Vorderwinkler KP, Artner DE, Jakob G, Mair J, Diensti F, Pichler M, Puschendorf B. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases. Clin Chem 1991;37:186-190.
20. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Schaffer F, Popper H, eds. Progress in liver diseases. vol 3. New York: Grune & Stratton, 1970.
21. Chase RA, Davies M, Trewby MA, Silk DBA, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology 1978;75:1033-1040.
22. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
23. Gerbes AL, Arendt RM, Gerzer R, Schnizer W, Jungst D, Paumgartner G, Wernze H. Role of atrial natriuretic factor, cyclic GMP and the renin-aldosterone system in acute volume regulation of healthy human subjects. Eur J Clin Invest 1988;18:425-429.
24. Knight KR, MacPhadyen K, Lepore DA, Kuwata N, Eadie PA, O'Brien BM. Enhancement of ischaemic rabbit skin flap survival with the antioxidant and free-radical scavenger N-acetylcysteine. Clin Sci 1991;81:31-36.
25. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomised, double-blind study. Crit Care Med 1994;22:1738-1746.